Craven House Capital PLC Notice of General Meeting and Migration from AIM (2769C)

TIDMCRV

RNS Number : 2769C

Craven House Capital PLC

27 June 2016

Craven House Capital plc ("Craven House Capital" or the "Company")

Notice of General Meeting

Migration from AIM to the Specialist Fund Segment

Commitments for up to $150 million in new equity

Notice of General Meeting and Migration

Craven House Capital (AIM: CRV) announces that it intends to cancel its quotation on the AIM and is seeking admission to the Specialist Fund Segment of the Main Market of the London Stock Exchange ("SFS"). The Board considers that the SFS represents a more mature and suitable market for the Company and intends to issue a circular to shareholders (the "Circular") today, containing a notice of a General Meeting ("GM") to be convened on 20 July 2016.

The resolutions to be put to shareholders at the GM will propose, inter alia, to cancel the Company's AIM quotation (subject to the successful admission to the SFS), to approve the migration to the SFS and to approve a simultaneous offer for a subscription of new shares to raise additional capital for the Company. Resolutions will also be proposed to adopt new Articles of Association and to undertake a share reorganisation such that the Company's shares will be redenominated in US dollars, reduced in nominal value by a small percentage and subsequently consolidated so that the shares each have a nominal value of US$1.00. The board believes that a consolidated share register and a quotation in US dollars is more suitable for international institutional and other investors and more reflective of our global portfolio, the majority of which is valued in US dollars.

If approved, it is expected that the Company's AIM quotation will be cancelled and the shares will commence trading on the SFS on 1 August 2016. A detailed timetable will be provided in the Circular.

Recent fundraising

The Company also announces that it has entered into conditional agreements with an investor for subscriptions of up to US$150 million in new ordinary shares, at 1.25p per share on a pre-consolidation basis. The Company intends that such investments would be made after the migration to the SFS over the next six months conditional on regulatory approval and execution of binding subscription agreements. There can be no guarantee that any capital investment in the Company will be made and further updates will be provided to the market in due course.

The Company has recently undertaken equity fundraisings on a private placement basis, as set out in the Company's announcements dated 17 May and 16 June 2016. The Board hopes to conclude further share issues on the same basis before the date of the GM. In the event of such further placings of shares, the Company will continue to make appropriate announcements.

Ends

For further information please contact:

 
 Craven House Capital Plc          Tel: 020 7002 1027 
  Mark Pajak 
  www.Cravenhousecapital.com 
 SI Capital                        Tel: 01483 413500 
  Broker 
  Nick Emerson 
  www.sicapital.co.uk 
  SPARK Advisory Partners           Tel: 0203 368 3550 
   Limited 
   Nominated Adviser 
   Matt Davis/Mark Brady 
   www.Sparkadvisorypartners.com

About Craven House Capital

Craven House Capital (AIM: CRV) is an investment company seeking deep value opportunities across the globe. It seeks to create long-term shareholder value on a per share basis by deploying patient capital. Craven House seeks to acquire real assets and operating companies that capable of generating steady cash flows.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCPGUBAQUPQGQQ

(END) Dow Jones Newswires

June 27, 2016 02:00 ET (06:00 GMT)

Craven House Capital (LSE:CRV)
Historical Stock Chart
From Mar 2024 to Apr 2024